Investigative Sites

How targeted AI can improve the performance of clinical trials.

In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.

Insights identify opportunities to optimize sponsor, CRO, and site collaborations.

Clinical trial liaisons rather serve as experts in their therapeutic areas and as clinical trial specialists to provide a suite of strategic advantages to benefit a study.

Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and monitoring, which could improve patient access and enhance the efficiency of clinical research.

A focus on data and process excellence advances product development.

How a deeper review of site budget and payment processes and technology is driving meaningful change in the industry.

Sponsors and CROs that work with these sites can better reach marginalized communities.

Results from survey of 100 site personnel suggest a disconnect is present between these stakeholders.

In this video interview, Kelli Aufderheide, director, laboratory decentralized trial solutions, IQVIA Laboratories, discusses the different types of labs in clinical research and what they offer.

Moving towards the development of mature quality management systems.

In this video interview, Jimmy Bechtel, vice president, site engagement, SCRS, provides an overview of themes discussed and his key takeaways from the most recent summit.

In this video interview, Jimmy Bechtel, vice president, site engagement, SCRS, discusses some key initiatives around decentralized capabilities and underrepresented patient populations.

In this video interview, Jimmy Bechtel, vice president, site engagement, SCRS, highlights ongoing leadership and payment initiatives for sites.

In this video interview, Jimmy Bechtel, vice president, site engagement, SCRS, discusses the importance of communication between CROs, sponsors, and sites.

In this video interview, Jimmy Bechtel, vice president, site engagement, SCRS, highlights how sites are bearing the burdens of cost and training with implementing new technologies.

In this video interview, Jimmy Bechtel, vice president, site engagement, SCRS, discusses challenges and trends he is currently hearing about from sites.

It takes a village to raise a trial, but most stakeholders are siloed on isolated islands.

In a fireside chat with ACT editor Andy Studna, Bowdish, from a clinical research cancer center, shares her experience with these relationships and how to streamline clinical operations.

A data-fueled framework for sponsors and CROs in navigating this shifting terrain.

Webinar Date/Time: Wednesday, November 13th, 2024 at 11am EST | 8am PST | 4pm GMT | 5pm CET

The role of the clinical research associate may be key in addressing challenges around the adoption of digital tools.

Webinar Date/Time: Thu, Oct 24, 2024 1:00 PM EDT

Webinar Date/Time: Wed, Oct 23, 2024 11:00 AM EDT

Improving accessibility drives faster and more efficient patient enrollment and a more diverse trial population.

While measuring and managing site costs can be challenging, these codes can aid in accounting for labor expenses, budgeting for sponsors, and more.

Webinar Date/Time: Wed, Sep 25, 2024 11:00 AM EDT

New investigators practicing in community-based settings bring enthusiasm and a fresh approach to clinical research, while also boosting collaboration and merging personal connection and patient-centric insights.

Webinar Date/Time: Tue, Aug 20, 2024 11:00 AM EDT

Giving sites and sponsors an effective tool for principled negotiations.